Back to search
Familial Hemophagocytic Lymphohistiocytosis Type 3 (FHL 3)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Familial Hemophagocytic Lymphohistiocytosis Type 3 (FHL 3) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Familial Hemophagocytic Lymphohistiocytosis Type 3 (FHL 3) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The investigators propose to replace HLA- partially compatible allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for FHL type 3 patients, with autologou…
Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple…
The purpose of this study is to learn more about the effects of (classification determinant) CD34+ stem cell selection on graft versus host disease (GVHD) in ch…